<DOC>
	<DOCNO>NCT02364960</DOCNO>
	<brief_summary>The purpose study create registry evaluate use intra-operative radiation therapy ( IORT ) study efficacy toxicity breast radiotherapy give intra-operatively single fraction breast conserving surgery ,</brief_summary>
	<brief_title>Targeted Intraoperative Therapy Registry Bethesda North Hospital ( TARGIT )</brief_title>
	<detailed_description>A registry trial design model original successful TARGIT protocol , continue use IORT select population woman , follow outcome regard local regional control , toxicity morbidity . Patients select breast conserve surgery , consider low risk local recurrence , eligible registry trial inform consent obtain . This single arm cohort study allow entry patient diagnose early stage breast cancer whose clinical stage suitable treat conservatively ( small tumor gross nodal involvement ) . Tumors 3.5 cm size .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Female Age 45 great Diagnosed operable invasive breast cancer , T1 T2 ( &lt; 3.5 cm ) , N0 , M0 , confirm cytological histological examination Suited breast conserving surgery Have ipsilateral ( side current cancer ) diagnostic mammogram within 12 month enrollment age 44 less Axillary lymph node positive breast cancer Invasive lobular cancer Tumor size &gt; 3.5 cm Extensive Intraductal Component ( EIC= &gt; 25 % lumpectomy specimen involve ductal carcinoma situ , DCIS ) assess surgical pathologic lumpectomy specimen Multicentric cancer breast amenable excision single lumpectomy Inability ass pathologic margin status Synchronous bilateral breast cancer time diagnosis . Ipsilateral breast previous cancer and/or prior infield radiation . Patients know BRCA1/2 gene mutation Neoadjuvant treatment ( hormone chemotherapy )</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>